ClinicalTrials.gov record
Completed No phase listed Observational

Synuclein-One Study

ClinicalTrials.gov ID: NCT04700722

Public ClinicalTrials.gov record NCT04700722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cutaneous Phosphorlyated α-synuclein Detection as a Biomarker of Synucleinopathy

Study identification

NCT ID
NCT04700722
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
CND Life Sciences
Other
Enrollment
428 participants

Conditions and interventions

Interventions

  • Skin Biopsy Diagnostic Test

Diagnostic Test

Eligibility (public fields only)

Age range
40 Years to 99 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2021
Primary completion
Dec 13, 2022
Completion
Nov 7, 2023
Last update posted
Jan 2, 2024

2021 – 2023

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
MD First Research Chandler Arizona 85286
CND Life Sciences Phoenix Arizona 85018
Movement Disorders Center of Arizona Scottsdale Arizona 85258
The Neuro Center Carlsbad California 92011
Providence St. John's Health Santa Monica California 90404
Rocky Mountain Movement Disorders Center, PC Englewood Colorado 80113
Aventura Neurology Aventura Florida 33180
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
UF College of Medicine Gainesville Florida 32608
Parkinson's Disease Treatment Center SWFL Port Charlotte Florida 33980
NorthShore University Health System Evanston Illinois 60201
Boston Medical Center Boston Massachusetts 02118
Beth Israel Lahey Health Boston Massachusetts 02215
Mayo Clinic Rochester Minnesota 55905
NYU Medical Center New York New York 10016
SouthShore Neurologic Patchogue New York 11772
Duke University Medical Center Durham North Carolina 27710
Providence Brain & Spine Institute Portland Oregon 97225
Vanderbilt University Medical Center Nashville Tennessee 37232
UTSouthwestern Dallas Texas 75390
Texas Movement Disorders Specialists Georgetown Texas 78628
Evergreen Health Kirkland Washington 98034
Swedish Neuroscience Research Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04700722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2024 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04700722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →